BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2017 12:33:29 AM | Browse: 1226 | Download: 2007
 |
Received |
|
2017-01-18 10:23 |
 |
Peer-Review Started |
|
2017-01-19 19:40 |
 |
To Make the First Decision |
|
2017-02-09 15:03 |
 |
Return for Revision |
|
2017-02-14 11:50 |
 |
Revised |
|
2017-03-07 23:47 |
 |
Second Decision |
|
2017-04-27 17:24 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2017-05-04 18:26 |
 |
Articles in Press |
|
2017-05-04 18:26 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2017-05-19 02:26 |
 |
Publish the Manuscript Online |
|
2017-05-27 00:33 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Transplantation |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation
|
Manuscript Source |
Invited Manuscript |
All Author List |
Daniele Nicolini, Andrea Agostini, Roberto Montalti, Federico Mocchegiani, Cinzia Mincarelli, Alessandra Mandolesi, Nicola L Robertson, Roberto Candelari, Andrea Giovagnogni and Marco Vivarelli |
Funding Agency and Grant Number |
|
Corresponding Author |
Daniele Nicolini, MD, PhD, Division of Hepatobiliary and Transplant Surgery, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, via Tronto n°10/a, 60126 Ancona,
Italy. daniele.nicolini@ospedaliriuniti.marche.it |
Key Words |
Liver transplantation; Recurrence-free survival; Hepatocellular carcinoma; Radiological response; Locoregional therapies; Inflammatory markers; Selection criteria |
Core Tip |
The response to loco-regional therapy and biological markers appear to stratify the prognosis of hepatocellular carcinoma patients awaiting liver transplantation (LT) better than morphological criteria; however, their role in the selection scheme still needs validation. We analysed a homogeneous cohort of 70 patients treated exclusively by transarterial chemoembolization (TACE) prior to LT; the radiological response was assessed by two different enhancing methods (mRECIST and EASL criteria) that provided an accurate preoperative estimation of histological necrosis. We also demonstrated that a lack of response to TACE and a high platelet-to-lymphocyte ratio before surgery are strongly predictive of tumour recurrence, independently of the Milan criteria status at referral. |
Publish Date |
2017-05-27 00:33 |
Citation |
Nicolini D, Agostini A, Montalti R, Mocchegiani F, Mincarelli C, Mandolesi A, Robertson NL, Candelari R, Giovagnoni A, Vivarelli M. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. World J Gastroenterol 2017; 23(20): 3690-3701 |
URL |
http://www.wjgnet.com/1007-9327/full/v23/i20/3690.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v23.i20.3690 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345